A number of investment brokers have recently updated their price targets on shares of The Joint Corp. (JYNT).
Most recent broker ratings
07/01/2016 – The Joint Corp. had its “buy” rating reiterated by analysts at Maxim Group. They now have a USD 5 price target on the stock.
06/24/2016 – The Joint Corp. was downgraded to “buy” by analysts at Feltl & Co..
08/17/2015 – The Joint Corp. had its “buy” rating reiterated by analysts at Roth Capital.
The share price of The Joint Corp. (JYNT) was down -3.91% during the last trading session, with a day high of 2.55. 60421 shares were traded on The Joint Corp.’s last session.
The stock’s 50 day moving average is 2.56 and its 200 day moving average is 2.72. The stock’s market capitalization is 31.32M. The Joint Corp. has a 52-week low of 1.85 and a 52-week high of 7.65.
The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. The Company has approximately 310 franchised, company-owned, or managed clinics in operation in over 30 states. In addition to its approximately 310 operating clinics, the Company has granted franchises either directly or through its regional developers for an additional over 170 clinics. The Company offers a range of membership and wellness packages. Each patient’s records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.